FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W53815900> ?p ?o ?g. }

• W53815900 endingPage "1473" @default.
• W53815900 startingPage "1464" @default.
• W53815900 abstract "The effect in combination therapy of high energy under water shock waves (HESW) and anticancer drugs for subcutaneous murine bladder cancer (MBT-2) in C3H/He mice was examined. HESW were generated by piezoceramics and directed to the subcutaneous tumor under ultrasonographic guidance. The subcutaneous tumor was exposed to HESW alone (100 MPa, 1000 shots, 3 shots/sec) or in combination with pirarubicin (THP, 5 mg/kg, i.p.) or carboplatin (CBDCA, 40 mg/kg, i.p.). Remarkable bleeding in the tumor was seen immediately after the exposure of HESW, destroyed cancer cells appeared after one day and wider and clearly bordered tumor necrosis was observed after three days. In the HESW alone therapy, tumor growth of smaller tumors (< 10 mm3, n = 8) were suppressed more than that of larger tumors (10-35 mm3, n = 11). Tumor growth ratio on the 14th day (TGR 14) (tumor volume on the 14th day/tumor volume on the 1st day) was examined in larger tumors. TGR 14 were 152.2 +/- 146.6 (mean +/- S.D.) in the control (n = 20), 116.3 +/- 98.9 in HESW alone (n = 11), 75.5 +/- 110.7 in THP alone (n = 8), 90.7 +/- 61.6 in CBDCA alone (n = 6), 75.8 +/- 72.2 in THP + HESW (n = 9), 3.2 +/- 4.5 in CBDCA + HESW (n = 8) and 0.8 +/- 1.3 in CBDCA + HESW 2 cycles (n = 9). Evident suppression on tumor growth was more often seen in CBDCA + HESW and CBDCA + HESW 2 cycles therapies than in the other therapies (p < 0.01). The cumulative survival rates were higher in CBDCA + HESW and CBDCA + HESW 2 cycles therapies than in the other therapies (p < 0.05). Tumor metastasis was seen only in the lungs of the dead mice after 19 days. Lung metastases were seen in 1/6 in the control, 0/5 in HESW alone, 1/5 in CBDCA alone, 0/6 in CBDCA + HESW and 1/5 in CBDCA + HESW 2 cycles therapy, respectively." @default.
• W53815900 created "2016-06-24" @default.
• W53815900 creator A5035693973 @default.
• W53815900 creator A5036834474 @default.
• W53815900 creator A5037438850 @default.
• W53815900 creator A5050773211 @default.
• W53815900 creator A5070733336 @default.
• W53815900 creator A5074418887 @default.
• W53815900 creator A5076273759 @default.
• W53815900 creator A5080700568 @default.
• W53815900 date "1994-01-01" @default.
• W53815900 modified "2023-10-17" @default.
• W53815900 title "COMBINATION THERAPY OF HIGH ENERGY UNDER WATER SHOCK WAVES AND ANTICANCER DRUGS FOR SUBCUTANEOUS MURINE BLADDER CANCER (MBT-2)" @default.
• W53815900 cites W142284400 @default.
• W53815900 cites W1601157041 @default.
• W53815900 cites W1673078421 @default.
• W53815900 cites W1999893525 @default.
• W53815900 cites W2019190718 @default.
• W53815900 cites W2032936221 @default.
• W53815900 cites W2035087698 @default.
• W53815900 cites W2076959162 @default.
• W53815900 cites W2082646217 @default.
• W53815900 cites W2088677219 @default.
• W53815900 cites W2166660862 @default.
• W53815900 cites W2397983550 @default.
• W53815900 cites W2408952928 @default.
• W53815900 cites W2412830565 @default.
• W53815900 cites W2414712569 @default.
• W53815900 cites W2432629030 @default.
• W53815900 cites W2440124948 @default.
• W53815900 cites W58815276 @default.
• W53815900 cites W2620290284 @default.
• W53815900 doi "https://doi.org/10.5980/jpnjurol1989.85.1464" @default.
• W53815900 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7990295" @default.
• W53815900 hasPublicationYear "1994" @default.
• W53815900 type Work @default.
• W53815900 sameAs 53815900 @default.
• W53815900 citedByCount "1" @default.
• W53815900 crossrefType "journal-article" @default.
• W53815900 hasAuthorship W53815900A5035693973 @default.
• W53815900 hasAuthorship W53815900A5036834474 @default.
• W53815900 hasAuthorship W53815900A5037438850 @default.
• W53815900 hasAuthorship W53815900A5050773211 @default.
• W53815900 hasAuthorship W53815900A5070733336 @default.
• W53815900 hasAuthorship W53815900A5074418887 @default.
• W53815900 hasAuthorship W53815900A5076273759 @default.
• W53815900 hasAuthorship W53815900A5080700568 @default.
• W53815900 hasBestOaLocation W538159001 @default.
• W53815900 hasConcept C121608353 @default.
• W53815900 hasConcept C126322002 @default.
• W53815900 hasConcept C126894567 @default.
• W53815900 hasConcept C2776694085 @default.
• W53815900 hasConcept C2778239845 @default.
• W53815900 hasConcept C2780352672 @default.
• W53815900 hasConcept C2781451048 @default.
• W53815900 hasConcept C71924100 @default.
• W53815900 hasConceptScore W53815900C121608353 @default.
• W53815900 hasConceptScore W53815900C126322002 @default.
• W53815900 hasConceptScore W53815900C126894567 @default.
• W53815900 hasConceptScore W53815900C2776694085 @default.
• W53815900 hasConceptScore W53815900C2778239845 @default.
• W53815900 hasConceptScore W53815900C2780352672 @default.
• W53815900 hasConceptScore W53815900C2781451048 @default.
• W53815900 hasConceptScore W53815900C71924100 @default.
• W53815900 hasIssue "10" @default.
• W53815900 hasLocation W538159001 @default.
• W53815900 hasLocation W538159002 @default.
• W53815900 hasOpenAccess W53815900 @default.
• W53815900 hasPrimaryLocation W538159001 @default.
• W53815900 hasRelatedWork W1488951420 @default.
• W53815900 hasRelatedWork W2011804124 @default.
• W53815900 hasRelatedWork W2078711083 @default.
• W53815900 hasRelatedWork W2085905477 @default.
• W53815900 hasRelatedWork W2317145945 @default.
• W53815900 hasRelatedWork W2330592550 @default.
• W53815900 hasRelatedWork W2333742875 @default.
• W53815900 hasRelatedWork W2560413935 @default.
• W53815900 hasRelatedWork W2590464532 @default.
• W53815900 hasRelatedWork W4233827388 @default.
• W53815900 hasVolume "85" @default.
• W53815900 isParatext "false" @default.
• W53815900 isRetracted "false" @default.
• W53815900 magId "53815900" @default.
• W53815900 workType "article" @default.